Cited by 111Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 50 of the 54 references it cites were found in a registry or an index.

Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin

Open access

Cao, Yiting, Eble, Joseph M., Moon, Ejung, Yuan, Hong, Weitzel, Douglas H., Landon, Chelsea D., Yu-Chih Nien, Charleen, Hanna, Gabi, Rich, Jeremy N., Provenzale, James M., Dewhirst, Mark W.·2013·Cancer Research

DOI 10.1158/0008-5472.can-12-1345PMC PMC3800255

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Hypoxia-inducible factor 1 (HIF-1) is a master transcription factor that controls cellular homeostasis. Although its activation benefits normal tissue, HIF-1 activation in tumors is a major risk factor for angiogenesis, therapeutic resistance, and poor prognosis. HIF-1 activity is usually suppressed under normoxic conditions because of rapid oxygen-dependent degradation of HIF-1α. Here, we show that, under normoxic conditions, HIF-1α is upregulated in tumor cells in response to doxorubicin, a chemotherapeutic agent used to treat many cancers. In addition, doxorubicin enhanced VEGF secretion by normoxic tumor cells and stimulated tumor angiogenesis. Doxorubicin-induced accumulation of HIF-1α in normoxic cells was caused by increased expression and activation of STAT1, the activation of which stimulated expression of iNOS and its synthesis of nitric oxide (NO) in tumor cells. Mechanistic investigations established that blocking NO synthesis or STAT1 activation was sufficient to attenuate the HIF-1α accumulation induced by doxorubicin in normoxic cancer cells. To our knowledge, this is the first report that a chemotherapeutic drug can induce HIF-1α accumulation in normoxic cells, an efficacy-limiting activity. Our results argue that HIF-1α-targeting strategies may enhance doxorubicin efficacy. More generally, they suggest a broader perspective on the design of combination chemotherapy approaches with immediate clinical impact. Cancer Res; 73(20); 6230–42. ©2013 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-12-1345

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

RETRACTED ARTICLE: HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs
Zhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
Retracted
RETRACTED: Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
Lee, K., Qian, D. Z., Rey, S., Wei, H., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812801106 · Cited by 289
Retracted
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 7×
“Hypoxia is one important factor for HIF-1 activation, VEGF expression and angiogenesis (1, 30, 39).”
Influential
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550 · cited 2×
“Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.”
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354
Self-citation

Show all 54 references

Sorted by citations

RETRACTED: Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
Samanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421438111 · Cited by 460
Retracted
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
Semenza, G. L. (2016) · The EMBO Journal · doi:10.15252/embj.201695204 · Cited by 380
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
Lee, K., Kuo, Y., Ho, Y., & Huang, Y. (2019) · Cancers · doi:10.3390/cancers11091334 · Cited by 270
Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
Mallini, P., Lennard, T. W. J., Kirby, J. A., & Meeson, A. P. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.09.008 · Cited by 247
RETRACTED: PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis
Samanta, D., Park, Y., Andrabi, S. A., Shelton, L. M., Gilkes, D. M., & Semenza, G. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0530 · Cited by 242
Retracted
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
Hompland, T., Fjeldbo, C. S., & Lyng, H. (2021) · Cancers · doi:10.3390/cancers13030499 · Cited by 186
The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
Luo, D., Wang, Z., Wu, J., Jiang, C., & Wu, J. (2014) · BioMed Research International · doi:10.1155/2014/409272 · Cited by 157
Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target
Lin, D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i42.12171 · Cited by 124
Targeting Autophagy in Breast Cancer
Cocco, S., Leone, A., Piezzo, M., Caputo, R., Lauro, V. D., Rella, F. D., Fusco, G., Capozzi, M., Gioia, G. D., Budillon, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217836 · Cited by 120
Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer
Dai, W., Yang, F., Ma, L., Fan, Y., He, B., He, Q., Wang, X., Zhang, H., & Zhang, Q. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.036 · Cited by 104
Hypoxia and free radicals: Role in tumor progression and the use of engineering-based platforms to address these relationships
Hielscher, A. C., & Gerecht, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.015 · Cited by 110
Tie2 Expression on Macrophages Is Required for Blood Vessel Reconstruction and Tumor Relapse after Chemotherapy
Chen, L., Li, J., Wang, F., Dai, C., Wu, F., Liu, X., Li, T., Glauben, R., Zhang, Y., Nie, G., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1114 · Cited by 112
Hypoxia Mediates Tumor Malignancy and Therapy Resistance
Luo, W., & Wang, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_1 · Cited by 94
Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors
Semenza, G. L. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.09.004 · Cited by 94
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
Lu, H., Tran, T. M. L., Park, Y., Chen, I., Lan, J., Xie, Y., & Semenza, G. L. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0270 · Cited by 96
Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy
Liu, Q., Guan, C., Liu, C., Li, H., Wu, J., & Sun, C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113861 · Cited by 86
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Seebacher, N. A., Krchniaková, M., Stacy, A. E., Skoda, J., & Jansson, P. J. (2021) · Antioxidants · doi:10.3390/antiox10111801 · Cited by 84
What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
Alexa‐Stratulat, T., Pešić, M., Gašparović, A. Č., Trougakos, I. P., & Riganti, C. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100643 · Cited by 77
Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models
Li, Y., Wang, M., Zhi, P., You, J., & Gao, J. (2017) · Oncotarget · doi:10.18632/oncotarget.23187 · Cited by 75
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71
Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy
Xie, Z., Guo, W.-W., Guo, N., Huang-Fu, M.-Y., Liu, H., Lin, M., Xu, W., Chen, J., Wang, T., Wei, Q., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.013 · Cited by 71
Hypoxia-Induced Phenotypes that Mediate Tumor Heterogeneity
Qian, J., & Rankin, E. B. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_3 · Cited by 73
The c‐MYC‐ABCB5 axis plays a pivotal role in 5‐fluorouracil resistance in human colon cancer cells
Kugimiya, N., Nishimoto, A., Hosoyama, T., Ueno, K., Enoki, T., Li, T., & Hamano, K. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12531 · Cited by 68
Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile
Dubbelboer, I. R., Pavlovic, N., Heindryckx, F., Sjögren, E., & Lennernäs, H. (2019) · Cancers · doi:10.3390/cancers11071024 · Cited by 59
Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage
Syukri, A., Budu, B., Hatta, M., Amir, M., Rohman, M. S., Mappangara, I., Kaelan, C., Wahyuni, S., Bukhari, A., Junita, A. R., et al. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103501 · Cited by 58
Nix-Mediated Mitophagy Modulates Mitochondrial Damage During Intestinal Inflammation
Vincent, G., Novak, E. A., Siow, V. S., Cunningham, K. E., Griffith, B. D., Comerford, T. E., Mentrup, H. L., Stolz, D. B., Loughran, P., Ranganathan, S., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7702 · Cited by 60
Targeting Aerobic Glycolysis and HIF-1α Expression Enhance Imiquimod-induced Apoptosis in Cancer Cells
Huang, S., Kao, J., Wu, C., Wang, S.-T., Lee, H., Liang, S., Chen, Y., & Shieh, J. (2014) · Oncotarget · doi:10.18632/oncotarget.1734 · Cited by 54
Autophagy and mitophagy interplay in melanoma progression
Maes, H., & Agostinis, P. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.07.003 · Cited by 50
Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
Calcabrini, C., Maffei, F., Turrini, E., & Fimognari, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00567 · Cited by 50
HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism
Zhang, M., Qiu, Q., Li, Z., Sachdeva, M., Min, H. D., Cardona, D. M., DeLaney, T. F., Han, T. X., Ma, Y., Luo, L., et al. (2015) · Radiation Research · doi:10.1667/rr14016.1 · Cited by 48
Self-citation
Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment
Schito, L. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00209.2018 · Cited by 49
HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4
Yu, M., Ozaki, T., Sun, D., Xing, H., Wei, B., An, J., Yang, J., Gao, Y., Liu, S., Kong, C., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01613-y · Cited by 45
Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment
Li, Y., Luo, J., Lin, M., Zhi, P., Guo, W.-W., Han, M. Y., You, J., & Gao, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00199 · Cited by 45
Overexpression of STAT1 suppresses angiogenesis under hypoxia by regulating VEGF‑A in human glioma cells
Zhang, Y., Jin, G., Zhang, J., Mi, R., Zhou, Y., Fan, W., Cheng, S., Song, W., Zhang, B., Ma, M., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.079 · Cited by 42
FTO activates PD-L1 promotes immunosuppression in breast cancer via the m6A/YTHDF3/PDK1 axis under hypoxic conditions
Wang, S., Zhang, X., Chen, Q., Wu, H., Cao, S., Zhao, S., Li, G., Wang, J., Gong, Y., Wang, X., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.026 · Cited by 42
Optimized acriflavine-loaded lipid nanocapsules as a safe and effective delivery system to treat breast cancer
Montigaud, Y., Učakar, B., Krishnamachary, B., Bhujwalla, Z. M., Féron, O., Véronique Préat, A., Danhier, F., Gallez, B., & Danhier, P. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.034 · Cited by 44
Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α
Shan, J., Xuan, Y., Zhang, Q., & Huang, J. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600266 · Cited by 41
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment
Perut, F., Carta, F., Bonuccelli, G., Grisendi, G., Pompo, G. D., Avnet, S., Sbrana, F. V., Hosogi, S., Dominici, M., Kusuzaki, K., et al. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1086339 · Cited by 39
Hypoxia‐inducible factor‐2α (HIF‐2α), but not HIF‐1α, is essential for hypoxic induction of class III β‐tubulin expression in human glioblastoma cells
Bordji, K., Grandval, A., Cuhna-Alves, L., Lechapt, E., & Bernaudin, M. (2014) · FEBS Journal · doi:10.1111/febs.13062 · Cited by 39
CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
Sulaiman, A., McGarry, S., Han, X., Liu, S., & Wang, L. (2019) · Cancers · doi:10.3390/cancers11081128 · Cited by 36
Hypoxia signaling and metastatic progression
Schito, L., & Rey-Keim, S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.001 · Cited by 35
The Role of the HIF-1α Transcription Factor in Increased Cell Division at Physiological Oxygen Tensions
Carrera, S., Senra, J. M., Acosta, M. I., Althubiti, M., Hammond, E. M., de Verdier, P. J., & Macip, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097938 · Cited by 37
Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species
Xu, L., Zhang, Z., Ding, Y., Wang, L., Cheng, Y., Meng, L., Wu, J., Yuan, A., Hu, Y., & Zhu, Y. (2019) · Biomaterials Science · doi:10.1039/c9bm00590k · Cited by 32
Chromobox Homolog 4 is Positively Correlated to Tumor Growth, Survival and Activation of HIF-1α Signaling in Human Osteosarcoma under Normoxic Condition
Yang, J., Cheng, D., Zhu, B., Zhou, S., Ying, T., & Yang, Q. (2016) · Journal of Cancer · doi:10.7150/jca.13749 · Cited by 31
Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells
Kozar, I., Cesi, G., Margue, C., Philippidou, D., & Kreis, S. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.04.005 · Cited by 31
Inhibition of Murine Breast Cancer Metastases by Hydrophilic As4S4 Nanoparticles Is Associated With Decreased ROS and HIF-1α Downregulation
Wang, T., Meng, J., Wang, C., Wen, T., Jia, M., Ge, Y., Xie, L., Hao, S., Liu, J., & Xu, H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00333 · Cited by 32
Emerging Role of Hypoxia-Inducible Factors (HIFs) in Modulating Autophagy: Perspectives on Cancer Therapy
Jalouli, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041752 · Cited by 31
Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers
Schito, L., Rey, S., Xu, P., Man, S., Cruz‐Muñoz, W., & Kerbel, R. S. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911416 · Cited by 29
Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha
Yun, B. D., Son, S. W., Choi, S. Y., Kuh, H. J., Oh, T., & Park, J. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189819 · Cited by 31
Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma
Ren, X., & Su, C. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11295 · Cited by 28
Loss of WAVE3 sensitizes triple-negative breast cancers to chemotherapeutics by inhibiting the STAT-HIF-1α-mediated angiogenesis
Davuluri, G., Schiemann, W. P., Plow, E. F., & Sossey‐Alaoui, K. (2014) · JAK-STAT · doi:10.1080/21623996.2015.1009276 · Cited by 26
Effects of Melatonin and Adrenomedullin in Reducing the Cardiotoxic Effects of Doxorubicin in Rats
Durdağı, G., PEHLİVAN, D. Y., Oyar, E. Ö., Bahçeci, S., & Ozbek, M. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09625-y · Cited by 26
Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks
Mirzaei, S., Ranjbar, B., Tackallou, S. H., & Aref, A. R. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154676 · Cited by 28
Hypoxia in the intestine or solid tumors: A beneficial or deleterious alarm signal?
Shehade, H., Oldenhove, G., & Moser, M. (2014) · European Journal of Immunology · doi:10.1002/eji.201444719 · Cited by 26
Atypical Cell Populations Associated with Acquired Resistance to Cytostatics and Cancer Stem Cell Features: The Role of Mitochondria in Nuclear Encapsulation
Díaz-Carballo, D., Gustmann, S., Jastrow, H., Acikelli, A. H., Dammann, P., Klein, J., Dembinski, U., Bardenheuer, W., Malak, S., Araúzo-Bravo, M. J., et al. (2014) · DNA and Cell Biology · doi:10.1089/dna.2014.2375 · Cited by 23
Anti-hypoxia nanosized drug delivery systems improving cancer therapy
Yan, W., Lang, T., Zhu, R., Zhu, X. G., Yu, H., Wu, T., Yin, Q., & Li, Y. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101376 · Cited by 21
Correlation between CT Perfusion Parameters and Microvessel Density and Vascular Endothelial Growth Factor in Adrenal Tumors
Qin, H.-Y., Sun, H., Wang, X., Bai, R., Li, Y., & Zhao, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079911 · Cited by 21
Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expression
Vitale, D. L., Spinelli, F. M., Dago, D. D., Icardi, A., Demarchi, G., Caon, I., García, M. G., Bolontrade, M. F., Passi, A. G., Cristina, C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26379 · Cited by 20
Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review
Liu, L., Bai, J., Hu, L., & Jiang, D. (2023) · Medicine · doi:10.1097/md.0000000000035493 · Cited by 23
Metronomic chemotherapy in cancer treatment: new wine in an old bottle
Wu, H., Zhou, H.-X., Chen, L., & Wang, S.-S. (2024) · Theranostics · doi:10.7150/thno.95619 · Cited by 26
Mn-doped MOF nanoparticles mitigating hypoxia via in-situ substitution strategy for dual-imaging guided combination treatment of microwave dynamic therapy and chemotherapy
Hong, Q., Hang, L., Diao, Y., Wang, H., Fang, L., Liu, W., Liu, J., Sun, H. L., Wang, J., Meng, X., et al. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.01.202 · Cited by 19
Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Ronald, J., Nixon, A. B., Marin, D., Gupta, R. T., Janas, G., Chen, W., Suhocki, P. V., Pabon‐Ramos, W. M., Sopko, D. R., Starr, M. D., et al. (2017) · Radiology · doi:10.1148/radiol.2017162555 · Cited by 19
Transcriptomic Profiles of Monocyte-Derived Macrophages in Response to Escherichia coli is Associated with the Host Genetics
Emam, M., Cánovas, Á., Islas‐Trejo, A., Fonseca, P. A. D. S., Medrano, J. F. F., & Mallard, B. A. (2020) · Scientific Reports · doi:10.1038/s41598-019-57089-0 · Cited by 17
Aqua-(2-formylbenzoato)triphenyltin(IV) induces cell cycle arrest and apoptosis in hypoxic triple negative breast cancer cells
Singh, V., Rana, N. K., Kashif, M., Manna, P. P., Baul, T. S. B., & Koch, B. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105484 · Cited by 18
Hsp105α suppresses Adriamycin‐induced cell death via nuclear localization signal‐dependent nuclear accumulation
Yamane, T., Saito, Y., Teshima, H., Hagino, M., Kakihana, A., Sato, S., Shimada, M., Kato, Y., Kuga, T., Yamagishi, N., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29062 · Cited by 18
Hypoxia A Typical Target in Human Lung Cancer Therapy
Ullah, A., Shehzadi, S., Ullah, N., Nawaz, T., Iqbal, H., & Aziz, T. (2023) · Current Protein and Peptide Science · doi:10.2174/0113892037252820231114045234 · Cited by 17
Comparative Approach to the Temporo-Spatial Organization of the Tumor Microenvironment
Langsten, K. L., Kim, J. H., Sarver, A. L., Dewhirst, M. W., & Modiano, J. F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01185 · Cited by 18
Self-citation
MoS2/LaF3 for enhanced photothermal therapy performance of poorly-differentiated hepatoma
Sun, L., Bai, H., Jiang, H., Zhang, P., Li, J., Qiao, W., Wang, D., Liu, G., & Wang, X. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112462 · Cited by 16
HIF1α Regulates IL17 Signaling Pathway Influencing Sensitivity of Taxane-Based Chemotherapy for Breast Cancer
Dai, H., Sheng, X., Wang, Y., Zhou, L., Lin, Y., Du, Y., Yang, F., Sha, R., Peng, J., Yao, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.729965 · Cited by 13
Hypoxia-Targeted Responsive Delivery of Doxorubicin and Digoxin for Synergistic Treatment of Triple-Negative Breast Cancer
Weng, L., Zhao, M., Chen, Z., & Zhu, L. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c01325 · Cited by 12
Pro-angiogenic effects of MDM2 through HIF-1α and NF-κB mediated mechanisms in LNCaP prostate cancer cells
Muthumani, P., Karthikeyan, A., Dhandayuthapani, S., Venkatesan, T., & Rathinavelu, A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3430-0 · Cited by 12
Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer
Zhang, H., Angelopoulos, N., Xu, Y., Grothey, A., Nunes, J., Stebbing, J., & Giamas, G. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3443-y · Cited by 11
Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation
Kane, J. M., Magliocco, A. M., Zhang, Q., Wang, D., Klimowicz, A., Harris, J., Simko, J. P., DeLaney, T. F., Kraybill, W. G., & Kirsch, D. G. (2018) · Sarcoma · doi:10.1155/2018/8310950 · Cited by 10
Inhibition of HIF1α-Dependent Upregulation of Phospho-l-Plastin Resensitizes Multiple Myeloma Cells to Frontline Therapy
Bosseler, M., Marani, V., Broukou, A., Lequeux, A., Kaoma, T., Schlesser, V., François, J.-H., Palissot, V., Berchem, G., Aouali, N., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061551 · Cited by 10
A glutathione-triggered precision explosive system for improving tumor chemosensitivity
Nie, Y., Xu, Y., Gao, Y., He, J., Sun, L., Chen, J., Cui, Y., Ge, H., & Ning, X. (2020) · Nano Research · doi:10.1007/s12274-020-3238-2 · Cited by 10
Radiation and chemotherapy variable response induced by tumor cell hypoxia: impact of radiation dose, anticancer drug, and type of cancer
Ibrahim, A. M., Nady, S., Shafaa, M. W., & Khalil, M. M. (2022) · Radiation and Environmental Biophysics · doi:10.1007/s00411-022-00974-6 · Cited by 10
Histone deacetylase inhibitor panobinostat in combination with rapamycin confers enhanced efficacy against triple-negative breast cancer
Wu, K., Zhang, H., Zhou, L., Chen, L., Mo, C., Xu, S., Lin, J., Kong, L., & Chen, X. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113362 · Cited by 10
Upregulation of sphingosine kinase 1 in response to doxorubicin generates an angiogenic response via stabilization of Snail
Bonica, J., Clarke, C. J., Obeid, L. M., Luberto, C., & Hannun, Y. A. (2023) · The FASEB Journal · doi:10.1096/fj.202201066r · Cited by 9
PHD-2/HIF-1α axis mediates doxorubicin-induced angiogenesis in SH-SY5Y neuroblastoma microenvironment: a potential survival mechanism
Abou‐Shanab, A. M., Gaser, O. A., Galal, N., Mohamed, A. M., Atta, D., Kamar, S. S., Magdy, S., Khedr, M. A., Elkhenany, H. A., & El‐Badri, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-89884-3 · Cited by 10
Modeling hypoxia facilitates cancer cell survival through downregulation of p53 expression
Zhang, Y., Yapryntseva, M. A., Vdovin, A., Maximchik, P. V., Zhivotovsky, B., & Gogvadze, V. G. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109553 · Cited by 9
Effect of preoperative cancer treatment on epidermal growth factor receptor (EGFR) receptor expression level in ABY-029 guided sarcoma surgery
Xu, X., Samkoe, K. S., & Henderson, E. R. (2020) · Molecular-Guided Surgery: Molecules, Devices, and Applications · doi:10.1117/12.2546963 · Cited by 8
Influences of aqua-(2-formylbenzoato) triphenyltin(IV) on regression of hypoxic solid tumor through mitochondrial mediated pathway by inhibiting Hif-1 alpha
Singh, V., Singh, R. K., Goswami, P., Manna, P. P., Baul, T. S. B., Mandal, A., Singh, A. K., & Koch, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-89761-z · Cited by 7
The Protein Phosphatase PPM1G Destabilizes HIF-1α Expression
Pyo, J., Ryu, J., Kim, W., Choi, J., Jeong, J., & Kim, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082297 · Cited by 8
Proteomic Analysis Reveals the Effects of Different Dietary Protein Levels on Growth and Development of Jersey-Yak
Yang, G., Dai, R., Ma, X., Huang, C., Ma, X., Li, X., La, Y., Dingkao, R., Renqing, J., Guo, X., et al. (2024) · Animals · doi:10.3390/ani14030406 · Cited by 6
Amniotic membrane promotes doxorubicin potency by suppressing SH-SY5Y neuroblastoma cell angiogenesis
Abou‐Shanab, A. M., Shouman, S., Hussein, A. E., Gaser, O. A., Magdy, S., Ashraf, E., Salah, R. A., Idris, O., & El‐Badri, N. (2025) · BMC Cancer · doi:10.1186/s12885-025-14442-z · Cited by 6
Combined temozolomide and ionizing radiation induces galectin-1 and galectin-3 expression in a model of human glioma
Bailey, L. A., Jamshidi‐Parsian, A., Patel, T., Koonce, N. A., Diekman, A. B., Cifarelli, C. P., Marples, B., & Griffin, R. J. (2015) · Tumor Microenvironment and Therapy · doi:10.1515/tumor-2015-0002 · Cited by 6
Hypoxia
Jensen, C. C., & Warfel, N. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00039-6 · Cited by 5
Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro
Pătraș, L., Fens, M. H. A. M., Vader, P., Barendrecht, A. D., Sesărman, A., Banciu, M., & Schiffelers, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175951 · Cited by 5
Preclinical autophagy modulatory nanomedicines: big challenges, slow advances
Romero, E. L., & Morilla, M. J. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1933428 · Cited by 4
ACY-241, a histone deacetylase 6 inhibitor, suppresses the epithelial–mesenchymal transition in lung cancer cells by downregulating hypoxia-inducible factor-1 alpha
Park, S., Lee, N., & Jeong, C. (2023) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2024.28.1.83 · Cited by 4
Cancer Stem Cells: An Ever-Hiding Foe
Wilczyński, J. R. (2022) · Experientia supplementum · doi:10.1007/978-3-030-91311-3_8 · Cited by 4
HIF inhibition: Current strategies and clinical challenges
Więch-Walów, A., Bartoszewska, S., Barton, A., Czechowicz, P., Dudzik, J., Wielockx, B., Collawn, J. F., & Bartoszewski, R. (2026) · Redox biology · doi:10.1016/j.redox.2026.104220 · Cited by 3
“In normoxic cancer cell lines, doxorubicin-induced HIF-1 α accumulation was shown to depend on STAT1 activity, leading to increase in inducible nitric oxide synthase (iNOS) and nitric oxide production [396].”
Concurrent tracking of anatomy and metabolism
Dewhirst, M. W. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0196-z · Cited by 3
Self-citation
Enrichment of breast cancer stem cells following cytotoxic chemotherapy is mediated by hypoxia-inducible factorsPreprint
Samanta, D., Gilkes, D. M., Xiang, L., Chaturvedi, P., & Semenza, G. L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.497729 · Cited by 4
Identification of prokineticin‐2 as potential pharmacodynamic biomarker for overcoming doxorubicin resistance in multicellular breast cancer spheroids
Vincenzi, M., Kremić, A., Tscheiller, N. M., Hsu, P., Chan, M. W. Y., Lattanzi, R., & Nebigil, C. G. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70204 · Cited by 2
[Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism].
Li, B., Yuan, L., Shi, R.-R., & Wang, J. (2015) · PubMed · Cited by 2
Therapeutic Potential
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_16 · Cited by 1
The Lymphatic System in Colorectal Cancer
Ceelen, W. (2022) · Elsevier eBooks · doi:10.1016/c2020-0-01507-0 · Cited by 1
Premetastatic Microenvironment
Maru, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-56024-1_13 · Cited by 1
Therapeutic Potential
Maru, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-56024-1_16 · Cited by 1

Authors: Cao, Y., Eble, J. M., Moon, E., Yuan, H., Weitzel, D. H., Landon, C. D., Yu-Chih Nien, C., Hanna, G., Rich, J. N., Provenzale, J. M., & Dewhirst, M. W.
Affiliations: University of North Carolina at Chapel Hill (US)
Authors' Affiliations: Departments of 1Radiation Oncology,2Surgery, 3Pathology, and 4Radiology, Duke University Medical Center, Durham; 5Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 6Department of Radiology, Mayo Clinic, Rochester, Minnesota; 7Department of Radiation Oncology, Stanford University, Stanford, California; and 8Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
Corresponding author: Cao, Yiting
Dewhirst, Mark W.
ORCID: Cao, Yiting
Eble, Joseph M.
Yuan, Hong
Landon, Chelsea D.
Rich, Jeremy N.
Dewhirst, Mark W.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2013-10-14
Volume: 73
Issue: 20
Pages: 6230-6242
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-12-1345
PMC: PMC3800255
OpenAlex: W2143643269
Cited by: 111
References: 54
Citations by year: 2026: 4 · 2025: 8 · 2024: 3 · 2023: 6 · 2022: 12 · 2021: 10 · 2020: 11 · 2019: 12 · 2018: 11 · 2017: 3 · 2016: 7 · 2015: 9 · 2014: 13 · 2013: 2
FWCI: 3.64
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (5p01ca042745-23)
National Cancer Institute (P01-CA-42745, R01CA040355, R01 CA40355, P01-CA042745, P50CA068438, P30CA014236)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: HIF-1α, doxorubicin, normoxia, cancer cells, STAT1, inducible nitric oxide synthase, nitric oxide, vascular endothelial growth factor, tumor angiogenesis, chemoresistance, combination chemotherapy, HIF-1α stabilization
MeSH terms: Animals, Antibiotics, Antineoplastic, Breast Neoplasms, Doxorubicin, Female, Humans, Mammary Neoplasms, Experimental, Mice, Nude, Nitric Oxide, Random Allocation, Transcription Factors, Up-Regulation, Cell Line, Tumor, STAT1 Transcription Factor, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Nitric Oxide Synthase Type II, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks